Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: Stereoselective bupivacaine block

British Journal of Pharmacology

Volumn 137, Issue 8, 2002, Pages 1269-1279

  González, Teresa ^a   Arias, Cristina ^a   Caballero, Ricardo ^a   Moreno, Ignacio ^a   Delpón, Eva ^a   Tamargo, Juan ^a   Valenzuela, Carmen ^a  

^a Instituto Nacional de Toxicologia   (Spain)

Author keywords

Bupivacaine; HERG; Levobupivacaine; Ropivacaine; Stereoselectivity

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; DEXTROBUPIVACAINE; LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; POTASSIUM CHANNEL; ROPIVACAINE; UNCLASSIFIED DRUG;

ANESTHESIA MECHANISM; ANESTHETIC RECOVERY; ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ELECTRIC POTENTIAL; FEMALE; INHIBITION KINETICS; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; STEREOCHEMISTRY; TIME;

AMIDES; ANIMALS; BUPIVACAINE; CATION TRANSPORT PROTEINS; CHO CELLS; CRICETINAE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; MEMBRANE POTENTIALS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; STEREOISOMERISM; TRANS-ACTIVATORS;

EID: 0036944998     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704978     Document Type: Article

References (36)

1. Aberg, G. (1972). Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol. Toxicol., 31,273-286.
2. Akerman, B., Hellberg, I.B. & Trossvik, C. (1988). Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol. Scand., 32, 571-578.
3. Armstrong, C.M. (1971). Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J. Gen. Physiol., 58, 413-437.
4. Clarkson, C.W. & Hondeghem, L.M. (1985). Mechanism for bupivacaine depression of cardiac conduction: Fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology, 62, 396-405.
5. Foster, R.H. & Markham, A. (2000). Levobupivacaine: A review of its pharmacology and use as a local anaesthetic. Drugs, 59, 551-579.
6. Franks, N.P. & Lieb, W.R. (1991). Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science, 254, 427-430.
7. Franqueza, L., Longobardo, M., Vicente, J., Delpón, E., Tamkun, M.M., Tamargo, J., Snyders, D.J. & Valenzuela, C. (1997). Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ. Res., 81, 1053-1064.
8. González, T., Arias, C., Moreno, I., Caballero, R., Delpón, E., Tamargo, J. & Valenzuela, C. (2002). Comparative effects of bupivacaine, levobupivacaine, and ropivacaine on HERG channels stably expressed in CHO cells. Biophys. J., 82, 581a.
9. González, T., Longobardo, M., Caballero, R., Delpón, E., Sinisterra, J.V., Tamargo, J. & Valenzuela, C. (2001a). Stereoselective effects of the enantiomers of a new local anaesthetic, IQB-9302, on a human cardiac potassium channel (Kv1.5). Br. J. Pharmacol., 132, 385-392.
10. + channels. J. Pharmacol. Exp. Ther., 296, 573-583.
11. Groban, L., Deal, D.D., Vernon, J.C., James, R.L. & Butterworth, J. (2000), Ventricular arrhythmias with or without programmed electrical stimulation after incremental overdosage with lidocaine, bupivacaine, levobupivacaine, and ropivacaine. Anesth. Analg., 91, 1103-1111.
12. Hamill, O.P., Marty, A., Neher, E, Sakmann, B. & Sigworth, F.J. (1981). Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfügers Arch., 391, 85-100.
13. 2+ destabilization of the inactivated state. Biophys. J., 77, 2534-2541.
14. Keating, M.T. & Sanguinetti, M.C. (1996). Molecular genetic insights into cardiovascular disease. Science, 272, 681-685.
15. Kotelko, D.M., Shnider, S.M., Dailey, P.A., Brizgys, R.V., Levinson, G., Shapiro, W.A., Koike, M. & Rosen, M.A. (1984). Bupivacaine-induced cardiac arrhythmias in sheep. Anesthesiology, 60, 10-18.
16. Lipka, L.J., Jiang, M. & Tseng, G.N. (1998). Differential effects of bupivacaine on cardiac K channels: Role of channel inactivation and subunit composition in drug-channel interaction. J. Cardiovasc. Electrophysiol., 9, 727-742.
17. Longobardo, M., Delpón, E., Caballero, R., Tamargo, J. & Valenzuela, C. (1998). Structural determinants of potency and steroselective block of hKv1.5 channels induced by local anesthetics. Mol. Pharmacol., 54, 162-169.
18. Luduena, F., Bogado, E. & Tullar, B. (1972). Optical isomers of mepivacaine and bupivacaine. Arch. Int. Pharmacodyn. Ther., 200, 359-369.
19. Mitcheson, J.S., Chen, J., Lin, M., Culberson, C. & Sanguinetti, M.C. (2000). A structural basis for drug-induced long QT syndrome. Proc. Natl. Acad. Sci. U.S.A., 97, 12329-12333.
20. Nau, C., Wang, S.Y., Strichartz, G.R. & Wang, G.K. (2000). Block of human heart hH1 sodium channels by the enantiomers of bupivacaine. Anesthesiology, 93, 1022-1033.
21. Roden, D.M., Lazzara, R., Rosen, M., Schwartz, P.J., Towbin, J. & Vincent, G.M. (1996). Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation, 94, 1996-2012.
22. Sanchez-Chapula, J. (1988). Effects of bupivacaine on membrane currents of guinea-pig ventricular myocytes. Eur. J. Pharmacol., 156, 303-308.
23. Kr potassium channel. Cell, 81,299-307.
24. + current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol., 96, 195-215.
25. Scott, D.B., Lee, A., Fagan, D., Bowler, G.M., Bloomfield, P. & Lundh, R. (1989). Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth. Analg., 69, 563-569.
26. Smith, P.L., Baukrowitz, T. & Yellen, G. (1996). The inward rectification mechanism of the HERG cardiac potassium channel. Nature, 379, 833-836.
27. Solomon, D., Bunegin, L. & Albin, M. (1990). The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs. Anesthesiology, 72, 341-346.
28. Kr channel. J. Gen. Physiol., 107, 611-619.
29. Strichartz, G.R. (1987). Local Anesthetics, 1st Ed., Berlin, Springer-Verlag.
30. Tamargo, J. (2000). Drug-induced torsade de pointes: From molecular biology to bedside. Jpn. J. Pharmacol., 83, 1-19.
31. Valenzuela, C., Delpón, E., Franqueza, L., Gay, P., Snyders, D.J. & Tamargo, J. (1997). Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. Anesthesiology, 86, 718-728.
32. Valenzuela, C., Delpón, E., Tamkun, M.M., Tamargo, J. & Snyders, D.J. (1995a). Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers. Biophys. J., 69, 418-427.
33. Valenzuela, C., Snyders, D.J., Bennett, P.B., Tamargo, J. & Hondeghem, L.M. (1995b), Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes. Circulation, 92, 3014-3024.
34. Wheeler, D.M., Bradley, E.L. & Woods, W.T. (1988). The electrophysiologic actions of lidocaine and bupivacaine in the isolated, perfused canine heart. Anesthesiology, 68, 201-212.
35. Woodhull, A.M. (1973). Ionic blockade of sodium channels in nerve. J. Gen. Physiol., 61, 687-708.
36. Zhang, S., Rajamani, S., Chen, Y., gong, Q., Rong, Y., Zhou, Z., Ruoho, A. & January, C.T. (2001). Cocaine blocks HERG, but not KvLQT1 + minK, potassium channels. Mol. Pharmacol., 59, 1069-1076.